These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 20028780)
1. Genetic analysis of extensively drug-resistant Mycobacterium tuberculosis strains in Lisbon, Portugal. Perdigão J; Macedo R; Malaquias A; Ferreira A; Brum L; Portugal I J Antimicrob Chemother; 2010 Feb; 65(2):224-7. PubMed ID: 20028780 [TBL] [Abstract][Full Text] [Related]
2. From multidrug-resistant to extensively drug-resistant tuberculosis in Lisbon, Portugal: the stepwise mode of resistance acquisition. Perdigão J; Macedo R; Silva C; Machado D; Couto I; Viveiros M; Jordao L; Portugal I J Antimicrob Chemother; 2013 Jan; 68(1):27-33. PubMed ID: 23054995 [TBL] [Abstract][Full Text] [Related]
3. Tuberculosis drug-resistance in Lisbon, Portugal: a 6-year overview. Perdigão J; Macedo R; Silva C; Pinto C; Furtado C; Brum L; Portugal I Clin Microbiol Infect; 2011 Sep; 17(9):1397-402. PubMed ID: 20731680 [TBL] [Abstract][Full Text] [Related]
4. Mycobacterial interspersed repetitive unit typing and mutational profile for multidrug-resistant and extensively drug-resistant tuberculosis surveillance in Portugal: a 3-year period overview. Silva C; Perdigão J; Jordão L; Portugal I Int J Antimicrob Agents; 2014 Dec; 44(6):546-51. PubMed ID: 25270633 [TBL] [Abstract][Full Text] [Related]
5. Novel multiplex allele-specific PCR assays for the detection of resistance to second-line drugs in Mycobacterium tuberculosis. Evans J; Segal H J Antimicrob Chemother; 2010 May; 65(5):897-900. PubMed ID: 20185419 [TBL] [Abstract][Full Text] [Related]
6. High-level resistance to isoniazid and ethionamide in multidrug-resistant Mycobacterium tuberculosis of the Lisboa family is associated with inhA double mutations. Machado D; Perdigão J; Ramos J; Couto I; Portugal I; Ritter C; Boettger EC; Viveiros M J Antimicrob Chemother; 2013 Aug; 68(8):1728-32. PubMed ID: 23539241 [TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco. Oudghiri A; Karimi H; Chetioui F; Zakham F; Bourkadi JE; Elmessaoudi MD; Laglaoui A; Chaoui I; El Mzibri M BMC Infect Dis; 2018 Feb; 18(1):98. PubMed ID: 29486710 [TBL] [Abstract][Full Text] [Related]
8. [Future prospects of molecular epidemiology in tuberculosis]. Matsumoto T; Iwamoto T Kekkaku; 2009 Dec; 84(12):783-4. PubMed ID: 20077862 [TBL] [Abstract][Full Text] [Related]
9. Multidrug-resistant tuberculosis in Lisbon, Portugal: a molecular epidemiological perspective. Perdigão J; Macedo R; João I; Fernandes E; Brum L; Portugal I Microb Drug Resist; 2008 Jun; 14(2):133-43. PubMed ID: 18573039 [TBL] [Abstract][Full Text] [Related]
10. Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa. Mlambo CK; Warren RM; Poswa X; Victor TC; Duse AG; Marais E Int J Tuberc Lung Dis; 2008 Jan; 12(1):99-104. PubMed ID: 18173885 [TBL] [Abstract][Full Text] [Related]
11. Rapid detection of drug resistance and mutational patterns of extensively drug-resistant strains by a novel GenoType® MTBDRsl assay. Singh AK; Maurya AK; Kant S; Umrao J; Kushwaha RA; Nag VL; Dhole TN J Postgrad Med; 2013; 59(3):179-85. PubMed ID: 24029194 [TBL] [Abstract][Full Text] [Related]
12. Analysis of rpsL and rrs mutations in Beijing and non-Beijing streptomycin-resistant Mycobacterium tuberculosis isolates from Singapore. Sun YJ; Luo JT; Wong SY; Lee AS Clin Microbiol Infect; 2010 Mar; 16(3):287-9. PubMed ID: 19519851 [TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolates from high prevalence tuberculosis states in Mexico. Juarez-Eusebio DM; Munro-Rojas D; Muñiz-Salazar R; Laniado-Laborín R; Martinez-Guarneros JA; Flores-López CA; Zenteno-Cuevas R Infect Genet Evol; 2017 Nov; 55():384-391. PubMed ID: 27637930 [TBL] [Abstract][Full Text] [Related]
14. Relationship between the isoniazid-resistant mutation katGS315T and the prevalence of MDR-/XDR-TB in Osaka, Japan. Ano H; Matsumoto T; Suetake T; Nagai T; Tamura Y; Takamatsu I; Iwasaki T; Matsuoka H; Sasada S; Tetsumoto S; Tsuyuguchi I; Kusunoki Y; Takashima T Int J Tuberc Lung Dis; 2008 Nov; 12(11):1300-5. PubMed ID: 18926041 [TBL] [Abstract][Full Text] [Related]
15. Genotyping and clinical characteristics of multidrug and extensively drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China. Yuan X; Zhang T; Kawakami K; Zhu J; Zheng W; Li H; Deng G; Tu S; Liu W BMC Infect Dis; 2013 Jul; 13():315. PubMed ID: 23849244 [TBL] [Abstract][Full Text] [Related]
16. Implication of the RD(Rio) Mycobacterium tuberculosis sublineage in multidrug resistant tuberculosis in Portugal. David S; Duarte EL; Leite CQ; Ribeiro JN; Maio JN; Paixão E; Portugal C; Sancho L; Germano de Sousa J Infect Genet Evol; 2012 Oct; 12(7):1362-7. PubMed ID: 22569099 [TBL] [Abstract][Full Text] [Related]
18. [The effects of gene mutation related to drug resistance and drug efflux pump in extensively drug-resistant tuberculosis clinical isolates]. Cui ZL; Wang XL; Wang J; Lu JM; Hu ZY Zhonghua Jie He He Hu Xi Za Zhi; 2010 Jul; 33(7):505-9. PubMed ID: 20979796 [TBL] [Abstract][Full Text] [Related]
19. Extensively drug-resistant tuberculosis: current challenges and threats. Jain A; Mondal R FEMS Immunol Med Microbiol; 2008 Jul; 53(2):145-50. PubMed ID: 18479439 [TBL] [Abstract][Full Text] [Related]
20. Genotypic diversity of multidrug-, quinolone- and extensively drug-resistant Mycobacterium tuberculosis isolates in Thailand. Disratthakit A; Meada S; Prammananan T; Thaipisuttikul I; Doi N; Chaiprasert A Infect Genet Evol; 2015 Jun; 32():432-9. PubMed ID: 25847698 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]